Vaccine experts question fourth shot as companies seek expanded authorization

Published March 21, 2022 9:45am ET



COVID-19 vaccine makers’ requests to authorize another round of booster shots have prompted a debate splitting the pharmaceutical companies and vaccine experts who say a fourth jab is not yet needed.

Pfizer and partner company BioNTech, as well as Moderna, the makers of the two-dose mRNA vaccines, have each requested expanded use authorization from federal regulators to administer another round of booster shots to adults, bringing the total number of shots to four.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.